Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impact of PCSK9 inhibitors on the quality of life of patients at high cardiovascular risk.

× No keyword cloud information.

15 in total

Review 1. Prevalence of plasma lipid disorders with an emphasis on LDL cholesterol in selected countries in the Asia-Pacific region.

Authors: Zhen-Vin Lee; Elmer Jasper Llanes; Renan Sukmawan; Nuntakorn Thongtang; Huynh Quang Tri Ho; Philip Barter
Journal: Lipids Health Dis Date: 2021-04-15 Impact factor: 3.876

2. LDL-cholesterol change and goal attainment following statin intensity titration among Asians in primary care: a retrospective cohort study.

Authors: Hao Sen Andrew Fang; Qiao Gao; Mong Li Lee; Wynne Hsu; Ngiap Chuan Tan
Journal: Lipids Health Dis Date: 2021-01-06 Impact factor: 3.876

3. Evaluation of cardiovascular risk factors in patients with familial hypercholesterolemia from the North-Eastern area of Romania.

Authors: Cristiana-Elena Vlad; Liliana Foia; Laura Florea; Irina-Iuliana Costache; Andreea Covic; Roxana Popescu; Delia Reurean-Pintilei; Adrian Covic
Journal: Lipids Health Dis Date: 2021-01-11 Impact factor: 3.876

4. PCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study.

Authors: Mingtong Xu; Xiaoxue Zhu; Junyan Wu; Yuling Zhang; Dong Zhao; Xuhong Wang; Yanhua Ding; Yu Cao; Chengqian Li; Wei Hu; Jianlong Sheng; Zhu Luo; Zeqi Zheng; Jinfang Hu; Jianying Liu; Xiaoyang Zhou; Aizong Shen; Xiaomei Ding; Yongdong Zhang; Yonggang Zhao; Yijing Li; Sheng Zhong; Shimin An; Jianjun Zou; Li Yan
Journal: BMC Med Date: 2022-01-18 Impact factor: 8.775

5. Prognostic significance of visit-to-visit variability, and maximum and minimum LDL cholesterol in diabetes mellitus.

Authors: Chang-Sheng Sheng; Ya Miao; Lili Ding; Yi Cheng; Dan Wang; Yulin Yang; Jingyan Tian
Journal: Lipids Health Dis Date: 2022-02-10 Impact factor: 3.876

6. Effect of alirocumab on coronary plaque in patients with coronary artery disease assessed by optical coherence tomography.

Authors: Fei Gao; Zhi Jian Wang; Xiao Teng Ma; Hua Shen; Li Xia Yang; Yu Jie Zhou
Journal: Lipids Health Dis Date: 2021-09-12 Impact factor: 3.876

7. Long-term hospital-based secondary prevention of coronary artery disease: a randomized controlled trial.

Authors: Anete Kaldal; Serena Tonstad; Jarle Jortveit
Journal: BMC Cardiovasc Disord Date: 2021-12-16 Impact factor: 2.298

Review 8. PCSK9 Biology and Its Role in Atherothrombosis.

Authors: Cristina Barale; Elena Melchionda; Alessandro Morotti; Isabella Russo
Journal: Int J Mol Sci Date: 2021-05-30 Impact factor: 5.923

9. Pemafibrate decreases triglycerides and small, dense LDL, but increases LDL-C depending on baseline triglycerides and LDL-C in type 2 diabetes patients with hypertriglyceridemia: an observational study.

Authors: Ichiro Komiya; Akira Yamamoto; Suguru Sunakawa; Tamio Wakugami
Journal: Lipids Health Dis Date: 2021-02-20 Impact factor: 3.876

10. Comparative effect of statin intensity between prediabetes and type 2 diabetes mellitus after implanting newer-generation drug-eluting stents in Korean acute myocardial infarction patients: a retrospective observational study.

Authors: Yong Hoon Kim; Ae-Young Her; Myung Ho Jeong; Byeong-Keuk Kim; Sung-Jin Hong; Seunghwan Kim; Chul-Min Ahn; Jung-Sun Kim; Young-Guk Ko; Donghoon Choi; Myeong-Ki Hong; Yangsoo Jang
Journal: BMC Cardiovasc Disord Date: 2021-08-09 Impact factor: 2.298